---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-22-000065"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T04:57:08.787516+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Landec shareholders approve amendment to 2019 Stock Incentive Plan increasing share reserve by 759,797 shares

## Summary
- Shareholders elected Katrina L. Houde, Nelson Obus, and Jeffrey L. Edwards to the board with votes ranging from 15.2M to 17.7M for each.
- Amendment increases share reserve from 2,000,000 to 2,759,797 shares (759,797 new shares) and increases ISO limit to same total.
- Non-employee director annual award limit increased from $120,000 to $350,000 per fiscal year.
- Ratified Ernst & Young as independent auditor for fiscal year ending May 28, 2023 with 24.2M for, 9k against.
- Advisory vote on named executive officer compensation approved: 20.2M for, 1.1M against, 324k abstain.

## SEC filing metadata
- accession: 0001005286-22-000065
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000065/0001005286-22-000065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000065/lndc-20221101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-22-000065
- JSON: https://secwatch.observer/filing/0001005286-22-000065.json
- Plain text: https://secwatch.observer/filing/0001005286-22-000065.txt

## Key facts
- Shareholder Votes
  LIFECORE BIOMEDICAL, INC. DE shareholders approved Approval of amendment to the Landec Corporation 2019 Stock Incentive Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Stockholders approved the amendment to the Landec Corporation 2019 Stock Incentive Plan, with votes as follows: For Against Abstain Broker Non-Votes 18,487,481 3,096,263 16,615 2,698,258
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000065/0001005286-22-000065-index.htm
- Shareholder Votes
  LIFECORE BIOMEDICAL, INC. DE shareholders approved Approval of non-binding advisory proposal on the executive compensation of the Company's named executive officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: Stockholders approved the compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes as follows: For Against Abstain Broker Non-Votes 20,189,411 1,086,858 324,090 2,698,258
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000065/0001005286-22-000065-index.htm
- Shareholder Votes
  LIFECORE BIOMEDICAL, INC. DE shareholders approved Election of three directors for a two-year term.
  - Proposal: director election
  - Outcome: passed
  source text: The voting results for the election of directors were as follows: Director Votes For Votes Withheld Broker Non-Votes Katrina L. Houde 15,180,997 6,419,362 2,698,258 Nelson Obus 17,689,049 3,911,310 2,698,258 Jeffrey L. Edwards 17,743,088 3,857,271 2,698,258
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000065/0001005286-22-000065-index.htm
- Shareholder Votes
  LIFECORE BIOMEDICAL, INC. DE shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending May 28, 2023 at the 2023-05-28 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-28
  source text: Stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending May 28, 2023, with votes as follows: For Against Abstain 24,245,636 8,975 44,006
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000065/0001005286-22-000065-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.